KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Gilead Sciences (GILD) Return on Capital Employed (2016 - 2026)

Gilead Sciences filings provide 17 years of Return on Capital Employed readings, the most recent being 21.34% for Q4 2025.

  • On a quarterly basis, Return on Capital Employed rose 1763.0% to 21.34% in Q4 2025 year-over-year; TTM through Dec 2025 was 21.34%, a 1763.0% increase, with the full-year FY2025 number at 21.23%, up 1781.0% from a year prior.
  • Return on Capital Employed hit 21.34% in Q4 2025 for Gilead Sciences, down from 23.4% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 23.4% in Q3 2025 to a low of 1.94% in Q3 2024.
  • Median Return on Capital Employed over the past 5 years was 15.65% (2023), compared with a mean of 13.79%.
  • Biggest five-year swings in Return on Capital Employed: crashed -1444bps in 2024 and later surged 2146bps in 2025.
  • Gilead Sciences' Return on Capital Employed stood at 17.74% in 2021, then fell by -20bps to 14.2% in 2022, then grew by 5bps to 14.92% in 2023, then crashed by -75bps to 3.71% in 2024, then surged by 475bps to 21.34% in 2025.
  • The last three reported values for Return on Capital Employed were 21.34% (Q4 2025), 23.4% (Q3 2025), and 17.94% (Q2 2025) per Business Quant data.